Abstract
Probiotics are microbes having tremendous potential to prevent gastrointestinal disorders. In current investigation, immunomodulatory action of probiotic Lacticaseibacillus rhamnosus MTCC-5897 was studied during exclusion, competition and displacement of Escherichia coli on intestinal epithelial (Caco-2) cells. The incubation of intestinal cells with Escherichia coli, enhanced downstream signalling and activated nuclear factor kappa B (NF-κB). This significantly increased (p < 0.01) the pro-inflammatory cytokines (IL-8, TNF-α, IFN-ϒ) expression. While, incubation of epithelial cells with Lacticaseibacillus rhamnosus during exclusion and competition with Escherichia coli, counteracted these enhanced expressions. The immunomodulatory feature of Lacticaseibacillus rhamnosus was also highlighted with increased (p < 0.05) transcription of toll-like receptor-2 (TLR-2) and single Ig IL-1-related receptor (SIGIRR) along with diminished expression of TLR-4. Likewise, attenuation (p < 0.05) of E. coli-mediated enhanced nuclear translocation of NF-κB p-65 subunit by Lacticaseibacillus rhamnosus during exclusion was confirmed with western blotting. Thus, present finding establishes the prophylactic potential of Lacticaseibacillus rhamnosus against exclusion of Escherichia coli in intestinal cells.
Similar content being viewed by others
References
Bahrami B, Macfarlane S, Macfarlane GT (2011) Induction of cytokine formation by human intestinal bacteria in gut epithelial cell lines. J Appl Microbiol 110(1):353–363. https://doi.org/10.1111/j.1365-2672.2010.04889.x
Belkaid Y, Hand TW (2014) Role of the microbiota in immunity and inflammation. Cell 157(1):121–141
Bereswill S, Fischer A, Dunay IR, Kühl AA, Göbel UB, Liesenfeld O, Heimesaat MM (2013) Pro-inflammatory potential of Escherichia coli strains K12 and Nissle 1917 in a murine model of acute ileitis. Eur J Microbiol Immunol 3(2):126–134
Bermudez-Brito M, Munoz-Quezada S, Gomez-Llorente C, Matencio E, Bernal MJ, Romero F, Gil A (2013) Cell-free culture supernatant of Bifidobacterium breve CNCM I-4035 decreases proinflammatory cytokines in human dendritic cells challenged with Salmonella typhi through TLR activation. PLoS ONE 8(3):59370. https://doi.org/10.1371/journal.pone.0059370
Bhat MI, Singh VK, Sharma D, Kapila S, Kapila R (2019a) Adherence capability and safety assessment of an indigenous probiotic strain Lactobacillus rhamnosus MTCC-5897. Microb Pathogen 130:120–130. https://doi.org/10.1016/j.micpath.2019.03.009
Bhat MI, Sowmya K, Kapila S, Kapila R (2019b) Potential probiotic Lactobacillus rhamnosus (MTCC-5897) inhibits Escherichia coli impaired intestinal barrier function by modulating the host tight junction gene response. Probiotics Antimicro 15:1–2. https://doi.org/10.1007/s12602-019-09608-8
Bron PA, Kleerebezem M, Brummer RJ, Cani PD, Mercenier A, MacDonald TT, Garcia-Rodenas CL, Wells JM (2017) Can probiotics modulate human disease by impacting intestinal barrier function? Br J Nutr 117(1):93–107. https://doi.org/10.1017/S0007114516004037
Chen L, Deng H, Cui H, Fang J, Zuo Z, Deng J, Li Y, Wang X, Zhao L (2018) Inflammatory responses and inflammation-associated diseases in organs. Oncotarget 9:7204
Chiu YH, Lu YC, Ou CC, Lin SL, Tsai CC, Huang CT, Lin MY (2013) Lactobacillus plantarum MYL26 induces endotoxin tolerance phenotype in Caco-2 cells. BMC Micro 13:190. https://doi.org/10.1186/1471-2180-13-190
Dhanani AS, Bagchi T (2013) Lactobacillus plantarum CS24.2 prevents Escherichia coli adhesion to HT- 29 cells and also down-regulates enteropathogen induced tumor necrosis factor-α and interleukin-8 expression. Microbiol Immunol 57(4):309–315. https://doi.org/10.1111/1348-0421.12038
Donato KA, Gareau MG, Wang YJJ, Sherman PM (2010) Lactobacillus rhamnosus GG attenuates interferon-γ and tumour necrosis factor-α induced barrier dysfunction and pro-inflammatory signalling. Microbiol 156(11):3288–3297. https://doi.org/10.1099/mic.0.040139
Duary RK, Batish VK, Grover S (2014) Immunomodulatory activity of two potential probiotic strains in LPS-stimulated HT-29 cells. Genes & Nutr 9(3):398. https://doi.org/10.1007/s12263-014-0398-2
Finamore A, Roselli M, Imbinto A, Seeboth J, Oswald IP, Mengheri E (2014) Lactobacillus amylovorus inhibits the TLR4 inflammatory signaling triggered by enterotoxigenic Escherichia coli via modulation of the negative regulators and involvement of TLR2 in intestinal Caco-2 cells and pig explants. PLoS ONE 9(4):94891. https://doi.org/10.1371/journal.pone.0094891
Galdeano CM, Cazorla SI, Dumit JML, Velez E, Perdigon G (2019) Beneficial effects of probiotic consumption on the immune system. Ann Nutr Metab 74(2):115–124. https://doi.org/10.1159/000496426
Ghadimi D, Helwig U, Schrezenmeir J, Heller KJ, de Vrese M (2012) Epigenetic imprinting by commensal probiotics inhibits the IL- 23/IL- 17 axis in an in vitro model of the intestinal mucosal immune system. J Leukoc Biol 92(4):895–911. https://doi.org/10.1189/jlb.0611286
Groeger D, O’Mahony L, Murphy EF, Bourke JF, Dinan TG, Kiely B, Shanahan F, Quigley EM (2013) Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut. Gut Microbes 4:325–339. https://doi.org/10.4161/gmic.25487
Gronbach K, Flade I, Holst O, Lindner B, Ruscheweyh HJ, Wittmann A, Menz S, Schwiertz A, Adam P, Stecher B, Josenhans C (2014) Endotoxicity of lipopolysaccharide as a determinant of T-cell mediated colitis induction in mice. Gastroenterology 146(3):765–775
Horvath A, Leber B, Schmerboeck B, Tawdrous M, Zettel G, Hartl A, Madl T, Stryeck S, Fuchs D, Lemesch S, Douschan P (2016) Randomised clinical trial: the effects of a multispecies probiotic vs. placebo on innate immune function, bacterial translocation and gut permeability in patients with cirrhosis. Aliment Pharmacol Ther 44:926–935. https://doi.org/10.1111/apt.13788
Huang IF, Lin IC, Liu PF, Cheng MF, Liu YC, Hsieh YD, Chen JJ, Chen CL, Chang HW, Shu CW (2015) Lactobacillus acidophilus attenuates Salmonella-induced intestinal inflammation via TGF-β signaling. BMC Microbiol 15(1):203. https://doi.org/10.1186/s12866-015-0546-x
Jia Y, Si W, Hong Z, Qu M, Zhu N, Liu S, Li G (2019) Toll-like receptor 2-mediated induction of avian β-defensin 9 by Lactobacillus rhamnosus and its cellular components in chicken intestinal epithelial cells. Food Agr Immuno 30(1):398–417. https://doi.org/10.1080/09540105.2019.1593325
Kawai T, Akira S (2009) The roles of TLRs, RLRs and NLRs in pathogen recognition. Int Immunol 21(4):317–337. https://doi.org/10.1093/intimm/dxp017
Kim SC, Tonkonogy SL, Albright CA, Tsang J, Balish EJ, Braun J, Huycke MM, Sartor RB (2005) Variable phenotypes of enterocolitis in interleukin 10-deficient mice mono-associated with two different commensal bacteria. Gastroenterology 128(4):891–906
Kim SW, Kim HM, Yang KM, Kim SA, Kim SK, An MJ, Park JJ, Lee SK, Kim TI, Kim WH, Cheon JH (2010) Bifidobacterium lactis inhibits NF-κB in intestinal epithelial cells and prevents acute colitis and colitis-associated colon cancer in mice. Inflamm Bowel Dis 16(9):1514–1525
Kittana H, Gomes-Neto JC, Heck K, Geis AL, Segura Muñoz RR, Cody LA, Schmaltz RJ, Bindels LB, Sinha R, Hostetter JM, Benson AK (2018) Commensal Escherichia coli strains can promote intestinal inflammation via differential interleukin-6 production. Front Immunol 9:2318
Koli P, Sudan S, Fitzgerald D, Adhya S, Kar S (2011) Conversion of commensal Escherichia coli K-12 to an invasive form via expression of a mutant histone-like protein. Mbio. https://doi.org/10.1128/mBio.00182-11
Konieczna P, Groeger D, Ziegler M, Frei R, Ferstl R, Shanahan F, Quigley EM, Kiely B, Akdis CA, O’Mahony L (2012) Bifidobacterium infantis 35624 administration induces Foxp3 T regulatory cells in human peripheral blood: potential role for myeloid and plasmacytoid dendritic cells. Gut 61:354–366. https://doi.org/10.1136/gutjnl-2011-300936
Laemmli UK (1970) SDS-page Laemmli method. Nature 227:680–685
Lazar V, Ditu L, Pircalabioru G, Gheorghe I, Curutiu C, Holban AM, Chifiriuc CM (2018) Aspects of gut microbiota and immune system interactions in infectious diseases, immunopathology and cancer. Front Immunol 9:1830. https://doi.org/10.3389/fimmu.2018.01830
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods 25:402–408. https://doi.org/10.1006/meth.2001.1262
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275
Milajerdi A, Mousavi SM, Sadeghi A, Salari-Moghaddam A, Parohan M, Larijani B, Esmaillzadeh A (2019) The effect of probiotics on inflammatory biomarkers: a meta-analysis of randomized clinical trials. Eur J Nutr. https://doi.org/10.1007/s00394-019-01931-8
Oh NS, Joung JY, Lee JY, Kim Y (2018) Probiotic and anti-inflammatory potential of Lactobacillus rhamnosus 4B15 and Lactobacillus gasseri 4M13 isolated from infant feces. PLoS ONE. https://doi.org/10.1371/journal.pone.0192021
Oriach CS, Robertson RC, Stanton C, Cryan JF, Dinan TG (2016) Food for thought: The role of nutrition in the microbiota-gut–brain axis. Clin Nutr Exp 6:25–38. https://doi.org/10.1016/j.yclnex.2016.01.003
Pinto MGV, Gomez MR, Seifert S, Watzl B, Holzapfel WH, Franz CM (2009) Lactobacilli stimulate the innate immune response and modulate the TLR expression of HT-29 intestinal epithelial cells in vitro. Int J Food Micro 133:86–93. https://doi.org/10.1016/j.ijfoodmicro.2009.05.013
Roselli M, Finamore A, Britti MS, Mengheri E (2006) Probiotic bacteria Bifidobacterium animalis MB5 and Lactobacillus rhamnosus GG protect intestinal Caco-2 cells from the inflammation associated response induced by enterotoxigenic Escherichia coli K88. Br J Nutr 95(6):1177–1184. https://doi.org/10.1079/bjn20051681
Saliganti V, Kapila R, Sharma R, Kapila S (2015) Feeding probiotic Lactobacillus rhamnosus (MTCC 5897) fermented milk to suckling mothers alleviates ovalbumin-induced allergic sensitisation in mice offspring. Br J Nutr 114(8):1168–2117. https://doi.org/10.1017/S000711451500286X
Shadnoush M, Hosseini RS, Mehrabi Y, Delpisheh A, Alipoor E, Faghfoori Z, Mohammadpour N, Moghadam JZ (2013) Probiotic yogurt affects pro-and anti-inflammatory factors in patients with inflammatory bowel disease. IJPR 12:929
Sharma R, Kapila R, Dass G, Kapila S (2014) Improvement in Th1/Th2 immune homeostasis, antioxidative status and resistance to pathogenic E. coli on consumption of probiotic Lactobacillus rhamnosus fermented milk in aging mice. Age 36(4):9686. https://doi.org/10.1007/s11357-014-9686-4
Shimazu T, Villena J, Tohno M, Fujie H, Hosoya S, Shimosato T, Aso H, Suda Y, Kawai Y, Saito T, Makino S (2012) Immunobiotic Lactobacillus jensenii elicits anti-inflammatory activity in porcine intestinal epithelial cells by modulating negative regulators of the Toll-like receptor signaling pathway. Infect Immune 80(1):276–288. https://doi.org/10.1128/IAI.05729-11
Takanashi N, Tomosada Y, Villena J, Murata K, Takahashi T, Chiba E, Tohno M, Shimazu T, Aso H, Suda Y, Ikegami S (2013) Advanced application of bovine intestinal epithelial cell line for evaluating regulatory effect of lactobacilli against heat-killed enterotoxigenic Escherichia coli-mediated inflammation. BMC Microbiol 13(1):54. https://doi.org/10.1186/1471-2180-13-54
Thursby E, Juge N (2017) Introduction to the human gut microbiota. Biochem J 474(11):1823–1836. https://doi.org/10.1042/BCJ20160510
Tomosada Y, Villena J, Murata K, Chiba E, Shimazu T, Aso H, Iwabuchi N, Xiao JZ, Saito T, Kitazawa H (2013) Immunoregulatory effect of bifidobacteria strains in porcine intestinal epithelial cells through modulation of ubiquitin-editing enzyme A20 expression. PLoS ONE 8(3):e59259. https://doi.org/10.1371/journal.pone.0059259
Villena J, Kitazawa H (2014) Modulation of intestinal TLR4-inflammatory signaling pathways by probiotic microorganisms: lessons learned from Lactobacillus jensenii TL2937. Front Immunol 4:512. https://doi.org/10.3389/fimmu.2013.00512
Wachi S, Kanmani P, Tomosada Y, Kobayashi H, Yuri T, Egusa S, Shimazu T, Suda Y, Aso H, Sugawara M, Saito T (2014) Lactobacillus delbrueckii TUA 4408 L and its extracellular polysaccharides attenuate enterotoxigenic Escherichia coli- induced inflammatory response in porcine intestinal epitheliocytes via Toll- like receptor- 2 and 4. Mol Nutr Food Res 58(10):2080–2093. https://doi.org/10.1002/mnfr.201400218
Yan F, Polk DB (2010) Disruption of NF-κB signalling by ancient microbial molecules: novel therapies of the future. BMJ. https://doi.org/10.1136/gut.2009.179614
Acknowledgements
The authors acknowledge ICAR-National Dairy Research Institute (NDRI) Karnal, for providing the laboratory facilities for execution of this work. We are also thankful to Department of Biotechnology, Ministry of Science and Technology, New Delhi for providing required funds.
Funding
The authors are highly indebted to the Department of Biotechnology, Ministry of Science and Technology, New Delhi for providing necessary funds. (BT/PR15109/PFN/20/1174/2015) required for the present work. The funding agency has no role in the design, analysis or writing of this article.
Author information
Authors and Affiliations
Contributions
TG, RK: Conceptualization; TG, HK: methodology; TG, RK, SK: formal analysis; TG: investigation; TG: writing—original draft; HK, SK: writing—review and editing; TG, HK: software; TG, RK: validation; RK: funding acquisition; RK: resources; RK: supervision.
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflicts of interest to declare that are relevant to the content of this article.
Additional information
Communicated by Erko Stackebrandt.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Gupta, T., Kaur, H., Kapila, S. et al. Potential probiotic Lacticaseibacillus rhamnosus MTCC-5897 attenuates Escherichia coli induced inflammatory response in intestinal cells. Arch Microbiol 203, 5703–5713 (2021). https://doi.org/10.1007/s00203-021-02541-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00203-021-02541-x